Clinical trials of Wegovy showed people lost an average of 14% of their body weight at 64 weeks.
Posted by The MeidasTouch Podcast, Checked
- Sources
- 5 support3 context
- Said
- 1 time·
- Confidence
- 75%
The MeidasTouch PodcastOct 27, 2026
The 64-week figure of about 14% average weight loss is supported by multiple sources, but it applies to the oral Wegovy pill (OASIS 4 trial), not the injectable pen, which was studied over 68 weeks at about 14.9–15%.
Our two reads of who says this, and how, disagree, so it counts as the post's own claim.
What was said
… It's actually closing in on it. Weight loss by HIMS offers access to a range of FDA approved GLP-1 medications, including the Wegovy pill and the Wegovy pen. With Wegovy, you can lose up to 20% of your body weight. People lost an average of 14% body weight at 64 weeks in a clinical trial of Wegovy alongside diet and exercise. You get an online consultation with a licensed provider, plus nutrition and lifestyle guidance, and 24/7 access to your care team, not just a prescription and a good luck. …
The MeidasTouch Podcast · · from the transcriptPost →What we found
Supports. Novo Nordisk and the OASIS 4 trial results report that people taking the Wegovy pill lost about 14% (13.6%) of body weight at 64 weeks when analyzed regardless of whether they stayed on treatment, versus about 2% on placebo.[2][3]
Supports. Independent health coverage (WebMD, Everyday Health, U.S. News) reports the same 64-week result of about 14% average loss for the Wegovy pill, with 13.6% and 14% both cited.[4][5][6]
Context. The 14% figure is the 'treatment policy' estimate; the 'if all patients stayed on treatment' estimate was about 17%, so the 14% figure is the more conservative reading.[2][3][6]
Context. The injectable Wegovy pen trials were 68 weeks long and reported about 14.9–15% loss, so the 64-week 14% figure belongs to the pill rather than the injection. The claim does not specify the formulation, but the sources tie the 14% at 64 weeks to the pill.[1][7][8]
Sources
8 sources: 1 fact-checker, 7 not rated
- 1Many US patients opt for obesity drug injections, defying ...reuters.com · fact-checker · cited for: context
- 2News Detailsnovonordisk.com · not rated · cited for: supports, context
- 3FDA Approves Oral Wegovy® Pill | Novo Nordisk U.S.novonordisk-us.com · not rated · cited for: supports, context
- 4First GLP-1 Pill for Weight Loss Gets FDA Approvaleverydayhealth.com · not rated · cited for: supports
- 5Wegovy Pill vs. Foundayo Pill: How the 2 New GLP-1 Drugs Comparehealth.usnews.com · not rated · cited for: supports
- 6FDA Approves Once-Daily Wegovy Pill as the First Oral ...webmd.com · not rated · cited for: supports, context
- 7September 2026 Clinical Product Review - novomedlink.comnovomedlink.com · not rated · cited for: context
- 8Zepbound vs Wegovy: What's the diference between them?drugs.com · not rated · cited for: context
Where this claim was made
Said in 1 published post